Taisho Pharmaceutical

OverviewSuggest Edit

Taisho Pharmaceutical Holdings is a company that specializes in the manufacture and sale of over-the-counter (OTC) drugs, prescription pharmaceuticals, and foods. Its main product lineups include macrolide antibiotics, type 2 diabetes mellitus agents, and transdermal anti-inflammatory analgesics.
TypePublic
Founded2011
Websitetaisho-holdings.co.jp

Latest Updates

Employees (est.) (Mar 2019)5,142
Share Price (Oct 2020)¥6.6 K(-3%)
Cybersecurity ratingAMore

Taisho Pharmaceutical Financials and Metrics

Taisho Pharmaceutical Revenue

Market capitalization (22-Oct-2020)

523.6b

Closing stock price (22-Oct-2020)

6.6k
Taisho Pharmaceutical's current market capitalization is ¥523.6 b.
Show all financial metrics

Taisho Pharmaceutical Cybersecurity Score

Cybersecurity ratingPremium dataset

A

97/100

SecurityScorecard logo

Taisho Pharmaceutical Online and Social Media Presence

Embed Graph

Taisho Pharmaceutical Frequently Asked Questions

  • When was Taisho Pharmaceutical founded?

    Taisho Pharmaceutical was founded in 2011.

  • How many employees does Taisho Pharmaceutical have?

    Taisho Pharmaceutical has 5,142 employees.

  • Who are Taisho Pharmaceutical competitors?

    Competitors of Taisho Pharmaceutical include Humanigen, Alimera Sciences and Duopharma Biotech.